Death after N-butylscopolaminium Bromide in horses
The FDA has received 36 reports of death in horses after N-butylscopolaminium Bromide. That is 47% of all reports for this medicine, compared with 11% across reports for all horse medicines, so it is reported unusually often with this medicine.
36Reports
97%Marked serious
0.0%Recovered
100%Died or euthanised
Same dayTypical onset
Sponsored
How soon it started
How the animals did
Problems reported at the same time
Age of the animals
About this medicine
Type: medicine.
Questions owners ask
- Can N-butylscopolaminium Bromide cause death in horses?
- 36 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
- How soon after a dose was it reported?
- In half of the reports with dates, it started within the same day of the first dose.
- What should I do?
- Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).
Death with similar medicines
- Death after Omeprazole 44 reports · 2.3% of its reports
- Death after Pergolide 93 reports · 7.5% of its reports
- Death after Ceftiofur 204 reports · 17% of its reports
- Death after Detomidine 95 reports · 9.6% of its reports
- Death after Flunixin Meglumine 148 reports · 24% of its reports
- Death after Ketamine 43 reports · 7.6% of its reports
- Death after Xylazine 58 reports · 12% of its reports
- Death after Hyaluronate Sodium 33 reports · 7.9% of its reports
- Death after Butorphanol 57 reports · 19% of its reports
- Death after Ponazuril 27 reports · 15% of its reports
All reported side effects of N-butylscopolaminium Bromide in horses · Medicines most reported with death